676-Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Irvine, Alan D. [1 ]
Paller, Amy S. [2 ,3 ]
Hamon, Sara [4 ]
Horowitz, Julie [4 ]
Farrell, Annamaria [4 ]
Hatsell, Sarah [4 ]
Ehmann, Peter [4 ]
Rodriguez Marco, Ainara [5 ]
Bansal, Ashish [4 ]
Chen, Zhen [4 ]
Levy, Stephane [4 ]
Cyr, Sonya L. [4 ]
机构：
[1] Trinity Coll Dublin, Dublin, Ireland
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Madrid, Spain
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; pediatric; bone alkaline phosphatase; dupilumab;
D O I：
10.1093/bjd/ljae266.050
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
676
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
    Irvine, A. D.
    Paller, A.
    Horowitz, J. E.
    Farrell, A.
    Hatsell, S.
    Ehmann, P.
    Rodriguez Marco, A.
    Tian, T.
    Cyr, S. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S110 - S110
  • [2] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
    Irvine, Alan D.
    Paller, Amy S.
    Horowitz, Julie E.
    Farrell, Annamaria
    Hatsell, Sarah
    Ehmann, Peter
    McDonald, Robert
    Marco, Ainara Rodriguez
    Tian, Tingting
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [3] Dupilumab treatment of children with moderate-to-severe atopic dermatitis increases bone alkaline phosphatase, a marker of bone mineralization
    Irvine, Alan D.
    Paller, Amy S.
    Hamon, Sara
    Horowitz, Julie
    Farrell, Annamaria
    Hatsell, Sarah
    Marco, Ainara Rodriguez
    Bansal, Ashish
    Chen, Zhen
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [4] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [5] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis
    Staumont-Salle, Delphine
    Barbarot, Sebastien
    Bouaziz, Jean David
    Chan, Chan
    Clibborn, Claire
    Du-Thanh, Aurelie
    Feeney, Claire
    Lejeune, Alexandre
    Misery, Laurent
    Nosbaum, Audrey
    Seneschal, Julien
    Soria, Angele
    Zhang, Fan
    JEADV CLINICAL PRACTICE, 2023, 2 (03): : 518 - 530
  • [6] EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis
    Agache, Ioana
    Akdis, Cezmi
    Akdis, Mubeccel
    Brockow, Knut
    Chivato, Tomas
    del Giacco, Stefano
    Eiwegger, Thomas
    Eyerich, Kilian
    Gimenez-Arnau, Ana
    Gutermuth, Jan
    Guttman-Yassky, Emma
    Maurer, Marcus
    Ogg, Graham
    Ong, Peck Y.
    O'Mahony, Liam
    Schwarze, Juergen
    Warner, Amena
    Werfel, Thomas
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2021, 76 (04) : 988 - 1009
  • [7] Rapid response to dupilumab treatment in children with moderate-to-severe atopic dermatitis: A case series
    Votto, Martina
    Delle Cave, Francesco
    De Filippo, Maria
    Marseglia, Alessia
    Marseglia, Gian Luigi
    Brazzelli, Valeria
    Licari, Amelia
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 31 - 33
  • [8] Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
    Griffiths, Christopher
    de Bruin-Weller, Marjolein
    Deleuran, Mette
    Fargnoli, Maria Concetta
    Staumont-Salle, Delphine
    Hong, Chih-Ho
    Sanchez-Carazo, Jose
    Foley, Peter
    Seo, Seong Jun
    Msihid, Jerome
    Chen, Zhen
    Cyr, Sonya L.
    Rossi, Ana B.
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1357 - 1372
  • [9] Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
    Christopher Griffiths
    Marjolein de Bruin-Weller
    Mette Deleuran
    Maria Concetta Fargnoli
    Delphine Staumont-Sallé
    Chih-ho Hong
    Jose Sánchez-Carazo
    Peter Foley
    Seong Jun Seo
    Jérôme Msihid
    Zhen Chen
    Sonya L. Cyr
    Ana B. Rossi
    Dermatology and Therapy, 2021, 11 : 1357 - 1372
  • [10] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
12345